These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 8446583)
1. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Chipman SD; Sweet HO; McBride DJ; Davisson MT; Marks SC; Shuldiner AR; Wenstrup RJ; Rowe DW; Shapiro JR Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1701-5. PubMed ID: 8446583 [TBL] [Abstract][Full Text] [Related]
2. OIM and related animal models of osteogenesis imperfecta. Shapiro JR; Mcbride DJ; Fedarko NS Connect Tissue Res; 1995; 31(4):265-8. PubMed ID: 15612365 [TBL] [Abstract][Full Text] [Related]
3. Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I. Willing MC; Cohn DH; Byers PH J Clin Invest; 1990 Jan; 85(1):282-90. PubMed ID: 2295701 [TBL] [Abstract][Full Text] [Related]
4. Identification of the oim mutation by dye terminator chemistry combined with automated direct DNA sequencing. Camacho NP; Dow D; Toledano TR; Buckmeyer JK; Gertner JM; Brayton CF; Raggio CL; Root L; Boskey AL J Orthop Res; 1998 Jan; 16(1):38-42. PubMed ID: 9565071 [TBL] [Abstract][Full Text] [Related]
5. Molecular heterogeneity in osteogenesis imperfecta type I. Willing MC; Pruchno CJ; Byers PH Am J Med Genet; 1993 Jan; 45(2):223-7. PubMed ID: 8456806 [TBL] [Abstract][Full Text] [Related]
6. Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta. Spotila LD; Constantinou CD; Sereda L; Ganguly A; Riggs BL; Prockop DJ Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5423-7. PubMed ID: 2052622 [TBL] [Abstract][Full Text] [Related]
7. Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density. Phillips CL; Bradley DA; Schlotzhauer CL; Bergfeld M; Libreros-Minotta C; Gawenis LR; Morris JS; Clarke LL; Hillman LS Bone; 2000 Aug; 27(2):219-26. PubMed ID: 10913914 [TBL] [Abstract][Full Text] [Related]
8. Bone geometry and strength measurements in aging mice with the oim mutation. McBride DJ; Shapiro JR; Dunn MG Calcif Tissue Int; 1998 Feb; 62(2):172-6. PubMed ID: 9437052 [TBL] [Abstract][Full Text] [Related]
9. An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen. Shapiro JR; Stover ML; Burn VE; McKinstry MB; Burshell AL; Chipman SD; Rowe DW J Clin Invest; 1992 Feb; 89(2):567-73. PubMed ID: 1737847 [TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle weakness in osteogenesis imperfecta mice. Gentry BA; Ferreira JA; McCambridge AJ; Brown M; Phillips CL Matrix Biol; 2010 Sep; 29(7):638-44. PubMed ID: 20619344 [TBL] [Abstract][Full Text] [Related]
11. Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix. Mundlos S; Chan D; Weng YM; Sillence DO; Cole WG; Bateman JF J Biol Chem; 1996 Aug; 271(35):21068-74. PubMed ID: 8702873 [TBL] [Abstract][Full Text] [Related]
12. Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress. Misof K; Landis WJ; Klaushofer K; Fratzl P J Clin Invest; 1997 Jul; 100(1):40-5. PubMed ID: 9202055 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2. Ha-Vinh R; Alanay Y; Bank RA; Campos-Xavier AB; Zankl A; Superti-Furga A; Bonafé L Am J Med Genet A; 2004 Dec; 131(2):115-20. PubMed ID: 15523624 [TBL] [Abstract][Full Text] [Related]
14. The material basis for reduced mechanical properties in oim mice bones. Camacho NP; Hou L; Toledano TR; Ilg WA; Brayton CF; Raggio CL; Root L; Boskey AL J Bone Miner Res; 1999 Feb; 14(2):264-72. PubMed ID: 9933481 [TBL] [Abstract][Full Text] [Related]
15. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease. Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191 [TBL] [Abstract][Full Text] [Related]
16. Morphological and biochemical studies of a mouse mutant (fro/fro) with bone fragility. Muriel MP; Bonaventure J; Stanescu R; Maroteaux P; Guénet JL; Stanescu V Bone; 1991; 12(4):241-8. PubMed ID: 1793673 [TBL] [Abstract][Full Text] [Related]
17. Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta. Saban J; Zussman MA; Havey R; Patwardhan AG; Schneider GB; King D Bone; 1996 Dec; 19(6):575-9. PubMed ID: 8968022 [TBL] [Abstract][Full Text] [Related]
18. The phenotypic features of osteogenesis imperfecta resulting from a mutation of the carboxyl-terminal pro alpha 1 (I) propeptide that impairs the assembly of type I procollagen and formation of the extracellular matrix. Cole WG; Chow CW; Bateman JF; Sillence DO J Med Genet; 1996 Nov; 33(11):965-7. PubMed ID: 8950680 [TBL] [Abstract][Full Text] [Related]
19. Multi-scale analysis of bone chemistry, morphology and mechanics in the oim model of osteogenesis imperfecta. Bart ZR; Hammond MA; Wallace JM Connect Tissue Res; 2014 Aug; 55 Suppl 1():4-8. PubMed ID: 25158170 [TBL] [Abstract][Full Text] [Related]
20. Col1A-2 Mutation in Osteogenesis Imperfecta Mice Contributes to Long Bone Fragility by Modifying Cell-Matrix Organization. André G; Chretien A; Demoulin A; Beersaerts M; Docquier PL; Behets C Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]